Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2655${count})

  • Biomarkers, 2021
    The Development of Novel Probes for Imaging Glucocerebrosidase Activity in Parkinson’s Disease

    Study Rationale:       
    Mutations that disable glucocerebrosidase (GBA), a protein that strips sugars from molecules in the membranes of brain cells, are associated with Parkinson’s disease (PD)...

  • Research Grant, 2021
    Parkinson’s Disease Patient Report of Problems (PD-PROP) Curation

    Study Rationale:
    What people with Parkinson’s feel and experience about their disease, and how it affects their lives, is of paramount importance to their care and participation in research. The...

  • Environmental Risk Factors, 2021
    Pesticide Exposure, Systems Biology and Parkinson’s Disease

    Study Rationale:    
    Pesticide exposure is among the most consistently and widely reported environmental risk factors for Parkinson’s disease (PD). However, research on specific pesticides in...

  • Environmental Risk Factors, 2021
    Environmental Risk Factors for Parkinson’s Disease in a Prospective Veteran Cohort

    Study Rationale:    
    Parkinson’s disease may be caused by exposure to toxic substances in the environment, but few of these have been identified. One reason may be that scientists have studied the...

  • Priority Biology, 2021
    Efficacy of PRKN Gene Delivery toward Mitigation of Alpha-synuclein-induced Degeneration

    Study Rationale:
    Genetic mutations that cause the functional loss of the PRKN gene and its corresponding protein, parkin, can cause early-onset Parkinson’s disease (PD). Regardless of the cause...

  • Target Advancement Program, 2021
    Exploring the Role of FAIM, an Inhibitor of Cell Death, in Parkinson’s Disease

    Study Rationale:
    Parkinson’s disease (PD) is characterized by the degeneration of dopamine-producing neurons in the brain. We recently discovered that a protein called FAIM can protect neurons from...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.